{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T07:28:48Z","timestamp":1790494128083,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1132975"],"award-info":[{"award-number":["1132975"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.actbio.2018.09.037","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T16:17:54Z","timestamp":1537892274000},"page":"278-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":94,"special_numbering":"C","title":["Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus"],"prefix":"10.1016","volume":"80","author":[{"given":"Reshma J.","family":"Nevagi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab G.","family":"Khalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waleed M.","family":"Hussein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R.","family":"Batzloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Capon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael F.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7257-807X","authenticated-orcid":false,"given":"Mariusz","family":"Skwarczynski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Istvan","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2018.09.037_b0005","series-title":"History of Vaccine Development","author":"Plotkin","year":"2011"},{"key":"10.1016\/j.actbio.2018.09.037_b0010","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2217\/nnm.14.187","article-title":"Recent advances in peptide-based subunit nanovaccines","volume":"9","author":"Skwarczynski","year":"2014","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.actbio.2018.09.037_b0015","series-title":"Peptide Applications in Biomedicine, Biotechnology and Bioengineering","first-page":"327","article-title":"12 \u2013 Peptide-based vaccines A2 \u2013 Koutsopoulos, Sotirios","author":"Nevagi","year":"2018"},{"key":"10.1016\/j.actbio.2018.09.037_b0020","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1039\/C5SC03892H","article-title":"Peptide-based synthetic vaccines","volume":"7","author":"Skwarczynski","year":"2016","journal-title":"Chem. Sci."},{"key":"10.1016\/j.actbio.2018.09.037_b0025","series-title":"Subunit vaccine delivery","author":"Foged","year":"2015"},{"key":"10.1016\/j.actbio.2018.09.037_b0030","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.it.2008.09.006","article-title":"New horizons in adjuvants for vaccine development","volume":"30","author":"Reed","year":"2009","journal-title":"Trends Immunol."},{"key":"10.1016\/j.actbio.2018.09.037_b0035","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nri2868","article-title":"Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns","volume":"10","author":"Bachmann","year":"2010","journal-title":"Nat. Rev. Immunol"},{"key":"10.1016\/j.actbio.2018.09.037_b0040","doi-asserted-by":"crossref","first-page":"5742","DOI":"10.1002\/anie.201002221","article-title":"Polyacrylate dendrimer nanoparticles: a self-adjuvanting vaccine delivery system","volume":"49","author":"Skwarczynski","year":"2010","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.actbio.2018.09.037_b0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0928-0987(01)00172-5","article-title":"Chitosan and its derivatives in mucosal drug and vaccine delivery","volume":"14","author":"van der Lubben","year":"2001","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2018.09.037_b0050","article-title":"Chitin, chitosan, and glycated chitosan regulate immune responses: the novel adjuvants for cancer vaccine","volume":"1\u20138","author":"Chen","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.actbio.2018.09.037_b0055","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijpharm.2008.10.033","article-title":"Chitosan formulations improve the immunogenicity of a GnRH-I peptide-based vaccine","volume":"369","author":"S\u00e1enz","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2018.09.037_b0060","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/pat.1306","article-title":"Preparation and properties of ionically cross-linked chitosan nanoparticles","volume":"20","author":"Liu","year":"2009","journal-title":"Polym. Adv. Technol."},{"key":"10.1016\/j.actbio.2018.09.037_b0065","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ijpharm.2013.07.034","article-title":"Chitosan nanoparticles: preparation, size evolution and stability","volume":"455","author":"Rampino","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2018.09.037_b0070","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1016\/j.vaccine.2010.01.011","article-title":"Chitosan-based nanoparticles for improving immunization against hepatitis B infection","volume":"28","author":"Prego","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2018.09.037_b0075","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/9125048","article-title":"Effect of chitosan and liposome nanoparticles as adjuvant codelivery on the immunoglobulin G subclass distribution in a mouse model","volume":"2017","author":"Haryono","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.actbio.2018.09.037_b0080","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1166\/jnn.2017.13067","article-title":"Non-conjugated chitosan-based nanoparticles to proteic antigens elicit similar humoral immune responses to those obtained with alum","volume":"17","author":"Izaguirre-Hern\u00e1ndez","year":"2017","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.actbio.2018.09.037_b0085","doi-asserted-by":"crossref","first-page":"39962","DOI":"10.1039\/C7RA06450K","article-title":"In vitro and in vivo investigation of chitosan\u2013polylysine polymeric nanoparticles for ovalbumin and CpG co-delivery","volume":"7","author":"Han","year":"2017","journal-title":"RSC Adv."},{"key":"10.1016\/j.actbio.2018.09.037_b0090","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.vaccine.2008.12.004","article-title":"New approach on the development of a mucosal vaccine against strangles: systemic and mucosal immune responses in a mouse model","volume":"27","author":"Florindo","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.actbio.2018.09.037_b0095","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biomaterials.2008.10.035","article-title":"The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-\u025b-caprolactone-based nanoparticles","volume":"30","author":"Florindo","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.09.037_b0100","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2217\/nnm.16.36","article-title":"Multilayer engineered nanoliposomes as a novel tool for oral delivery of lipopeptide-based vaccines against group A Streptococcus","volume":"11","author":"Marasini","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.actbio.2018.09.037_b0105","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.2217\/nnm-2016-0291","article-title":"Double adjuvanting strategy for peptide-based vaccines: trimethyl chitosan nanoparticles for lipopeptide delivery","volume":"11","author":"Marasini","year":"2016","journal-title":"Nanomedicine (Lond)"},{"key":"10.1016\/j.actbio.2018.09.037_b0110","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/mic.0.081448-0","article-title":"Poly-\u03b3-glutamic acid: production, properties and applications","volume":"161","author":"Ogunleye","year":"2015","journal-title":"Microbiology"},{"key":"10.1016\/j.actbio.2018.09.037_b0115","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/CMR.13.3.470","article-title":"Pathogenesis of group A streptococcal infections","volume":"13","author":"Cunningham","year":"2000","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actbio.2018.09.037_b0120","doi-asserted-by":"crossref","first-page":"4204","DOI":"10.3390\/v7082818","article-title":"Evaluation of trichodysplasia spinulosa-associated polyomavirus capsid protein as a new carrier for construction of chimeric virus-like particles harboring foreign epitopes","volume":"7","author":"Gedvilaite","year":"2015","journal-title":"Viruses"},{"key":"10.1016\/j.actbio.2018.09.037_b0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114155","article-title":"The grafting of universal T-helper epitopes enhances immunogenicity of HIV-1 Tat concurrently improving its safety profile","volume":"9","author":"Kashi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.actbio.2018.09.037_b0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1745-7580-6-12","volume":"6","author":"Cong","year":"2010","journal-title":"Immunome Res."},{"key":"10.1016\/j.actbio.2018.09.037_b0135","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1021\/jm501514h","article-title":"Polyacrylate-based delivery system for self-adjuvanting anticancer peptide vaccine","volume":"58","author":"Liu","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.actbio.2018.09.037_b0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0144-8617(98)00009-5","article-title":"Preparation and NMR characterization of highly substitutedN-trimethyl chitosan chloride","volume":"36","author":"Sieval","year":"1998","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.actbio.2018.09.037_b0145","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10856-008-3659-z","article-title":"Trimethyl chitosan and its applications in drug delivery","volume":"20","author":"Mourya","year":"2009","journal-title":"J. Mater. Sci. Mater. Med."},{"key":"10.1016\/j.actbio.2018.09.037_b0150","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.actbio.2016.04.012","article-title":"Liposome-based intranasal delivery of lipopeptide vaccine candidates against group A streptococcus","volume":"41","author":"Ghaffar","year":"2016","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actbio.2018.09.037_b0155","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1128\/IAI.71.5.2373-2383.2003","article-title":"Potential of lipid core peptide technology as a novel self-adjuvanting vaccine delivery system for multiple different synthetic peptide immunogens","volume":"71","author":"Olive","year":"2003","journal-title":"Infect. Immun."},{"key":"10.1016\/j.actbio.2018.09.037_b0160","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/74719","article-title":"New multi-determinant strategy for a group A streptococcal vaccine designed for the Australian Aboriginal population","volume":"6","author":"Brandt","year":"2000","journal-title":"Nat. Med."},{"key":"10.1016\/j.actbio.2018.09.037_b0165","doi-asserted-by":"crossref","first-page":"3642","DOI":"10.1016\/j.biomaterials.2008.05.026","article-title":"Synthesis, characterization and in vitro biological properties of O-methyl free N, N, N-trimethylated chitosan","volume":"29","author":"Verheul","year":"2008","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2018.09.037_b0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-409X(01)00197-1","article-title":"Chitosan for mucosal vaccination","volume":"52","author":"Van der Lubben","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.actbio.2018.09.037_b0175","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.actbio.2018.09.037_b0180","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0928-0987(98)00016-5","article-title":"Chitosan for enhanced intestinal permeability: prospects for derivatives soluble in neutral and basic environments","volume":"7","author":"Kotze","year":"1999","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2018.09.037_b0185","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/1520-6017(200007)89:7<951::AID-JPS13>3.0.CO;2-1","article-title":"Intestinal absorption of octreotide: N-trimethyl chitosan chloride (TMC) ameliorates the permeability and absorption properties of the somatostatin analogue in vitro and in vivo","volume":"89","author":"Thanou","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.actbio.2018.09.037_b0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0378-5173(01)00914-0","article-title":"Effect of the degree of quaternisation of N-trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia","volume":"232","author":"Hamman","year":"2002","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2018.09.037_b0195","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1002\/cbic.200800196","article-title":"Synthesis and characterization of a long, rigid photoswitchable cross-linker for promoting peptide and protein conformational change","volume":"9","author":"Zhang","year":"2008","journal-title":"ChemBioChem"},{"key":"10.1016\/j.actbio.2018.09.037_b0200","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.ejpb.2012.07.005","article-title":"Development of a novel mucosal vaccine against strangles by supercritical enhanced atomization spray-drying of Streptococcus equi extracts and evaluation in a mouse model","volume":"82","author":"Rodrigues","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2018.09.037_b0205","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/mabi.201200425","article-title":"Buffer-stable chitosan-polyglutamic acid hybrid nanoparticles for biomedical applications","volume":"13","author":"Malhotra","year":"2013","journal-title":"Macromol. Biosci."},{"key":"10.1016\/j.actbio.2018.09.037_b0210","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.addr.2008.09.005","article-title":"Nanoparticles for nasal vaccination","volume":"61","author":"Csaba","year":"2009","journal-title":"Adv. Drug Del. Rev."},{"key":"10.1016\/j.actbio.2018.09.037_b0215","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jconrel.2005.02.027","article-title":"Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles","volume":"105","author":"Kwon","year":"2005","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actbio.2018.09.037_b0220","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle\u2013cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.actbio.2018.09.037_b0225","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0092-8674(01)00449-4","article-title":"Dendritic cells: Specialized and regulated antigen processing machines","volume":"106","author":"Mellman","year":"2001","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2018.09.037_b0230","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.actbio.2018.09.037_b0235","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.actbio.2018.09.037_b0240","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jconrel.2009.11.018","article-title":"Efficient induction of immune responses through intradermal vaccination with N-trimethyl chitosan containing antigen formulations","volume":"142","author":"Bal","year":"2010","journal-title":"J. Controlled Release"},{"key":"10.1016\/j.actbio.2018.09.037_b0245","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.3390\/molecules22112008","article-title":"Biodegradable chitosan decreases the immune response to trichinella spiralis in mice","volume":"22","author":"Brodaczewska","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.actbio.2018.09.037_b0250","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1002\/1873-3468.12254","article-title":"Streptococcus pyogenes adhesion and colonization","volume":"590","author":"Brouwer","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.actbio.2018.09.037_b0255","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1016\/j.bmc.2016.03.063","article-title":"Structure\u2013activity relationship of lipid core peptide-based group A Streptococcus vaccine candidates","volume":"24","author":"Chan","year":"2016","journal-title":"Biorg. Med. Chem."},{"key":"10.1016\/j.actbio.2018.09.037_b0260","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2217\/nnm.14.190","article-title":"Group A Streptococcal vaccine candidate: contribution of epitope to size, antigen presenting cell interaction and immunogenicity","volume":"9","author":"Zaman","year":"2014","journal-title":"Nanomedicine"},{"key":"10.1016\/j.actbio.2018.09.037_b0265","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2174\/1567201813666160721141322","article-title":"Highly immunogenic trimethyl chitosan-based delivery system for intranasal lipopeptide vaccines against group A streptococcus","volume":"14","author":"Marasini","year":"2017","journal-title":"Curr. Drug Del."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611830566X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S174270611830566X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T17:10:07Z","timestamp":1761671407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S174270611830566X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":53,"alternative-id":["S174270611830566X"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2018.09.037","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyglutamic acid-trimethyl chitosan-based intranasal peptide nano-vaccine induces potent immune responses against group A streptococcus","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2018.09.037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}